Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol - Ishiguro, Nobuhisa; Morioka, Ichiro; Nakano, Takashi; Furukawa, Masashi; Tanaka, Shintaro; Kinoshita, Masahiro; Manabe, Atsushi (BMC infectious diseases, 2021)
Keywords: Active control; Antiviral drugs; Baloxavir; Body temperature; Child; Children; Clinical trial protocol; Clinical trials; Comparative analysis; Comparative studies; Complications; Coronaviruses; Cough; COVID-19; Demographic aspects; Diagnosis; Diagnostic tests; Disease transmission; Dosage and administration; Drug dosages; Drug therapy; Endonuclease; Guardians; Hospitalization; Infections; Influenza; Informed consent; Japanese; Oseltamivir; Oseltamivir phosphate; Patients; Pediatrics; Polymerase chain reaction; Respiratory diseases; Reverse transcription; Safety; Severe acute respiratory syndrome coronavirus 2; Signs and symptoms; Study Protocol; Teenagers; Viruses; Weight; Japan